EGFR and neoplasm: Downstream signaling pathways, such as PI3K/AKT and RAS/MAPK, can be activated by EGFR and subsequently promote tumor progression and metastasis.91 EGFR has also been reported as a hypoxia-independent driver of HIF expression.